Kevin Wyckoff

Kevin Wyckoff is an experienced regulatory affairs professional with a robust background in the pharmaceutical and diagnostics industries. At Ferring Pharmaceuticals, Kevin served as Sr. Director of Regulatory Affairs for US Therapeutic Area Strategy, leading critical projects related to combination products and regulatory submissions. Prior roles include VP of Quality, Regulatory & Clinical Affairs at First Light BioSciences and VP of Quality, Regulatory & Compliance at Prominex, where Kevin established regulatory functions for innovative technologies. Kevin also held various leadership roles at Ortho Clinical Diagnostics, contributing to regulatory strategies for in vitro diagnostic products, and at Stago, where Kevin built a regulatory affairs team for North America. Kevin holds a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science in Chemistry from Louisiana State University.